[1]
World Health Organization: Fact Sheet on Cancer.
https://www.who.int/news-room/fact-sheets/detail/cancer (Accessed November 20, 2019).
[2]
Stewart, B.W.; Wild, C.P. World Cancer Report; 2014; ISBN (PDF) 978-92-832-0443-5; International Agency for Research on Cancer, Lyon, France.
[3]
Garcia, S.N.; Guedes, R.C.; Marques, M.M. Unlocking the potential of HK2 in cancer metabolism and therapeutics. Curr. Med. Chem., 2019, 26(41), 7285-7322.
[http://dx.doi.org/10.2174/0929867326666181213092652]
[http://dx.doi.org/10.2174/0929867326666181213092652]
[4]
Lopes, E.A.; Gomes, S.; Saraiva, L.; Santos, M.M.M. Small molecules targeting mutant p53: A promising approach for cancer treatment. Curr. Med. Chem., 2019, 26(41), 7323-7336.
[http://dx.doi.org/10.2174/0929867325666181116124308]
[http://dx.doi.org/10.2174/0929867325666181116124308]
[5]
Chiacchio, M.A.; Lanza, G.; Chiacchio, U.; Giofrè, S.V.; Romeo, R.; Iannazzo, D.; Legnani, L. Oxazole-based compounds as anticancer agents. Curr. Med. Chem., 2019, 26(41), 7337-7371.
[http://dx.doi.org/10.2174/0929867326666181203130402]
[http://dx.doi.org/10.2174/0929867326666181203130402]
[6]
Pilli, R.A.; de Toledo, I.; Meirelles, M.A.; Grigolo, T.A. Goniothalamin-related styryl lactones: Isolation, synthesis, biological activity and mode of action. Curr. Med. Chem., 2019, 26(41), 7372-7451.
[http://dx.doi.org/10.2174/0929867325666181009161439]
[http://dx.doi.org/10.2174/0929867325666181009161439]
[7]
Andrade, M.A.; Martins, L.M.D.R.S. Novel chemotherapeutic agents - The contribution of scorpionates. Curr. Med. Chem., 2019, 26(41), 7452-7475.
[http://dx.doi.org/10.2174/0929867325666180914104237]
[http://dx.doi.org/10.2174/0929867325666180914104237]
[8]
Phillips, A.M.F.; Pombeiro, A.J.L. Transition metal-based prodrugs for anticancer drug delivery. Curr. Med. Chem., 2019, 26(41), 7476-7519.
[http://dx.doi.org/10.2174/0929867326666181203141122]
[http://dx.doi.org/10.2174/0929867326666181203141122]
[9]
Dias, A.R.; Costa-Rodrigues, J.; Teixeira, C.; Prudêncio, C.; Gomes, P.; Ferraz, R. Ionic liquids for topical delivery in cancer. Curr. Med. Chem., 2019, 26(41), 7520-7532.
[http://dx.doi.org/10.2174/0929867325666181026110227]
[http://dx.doi.org/10.2174/0929867325666181026110227]
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
20
1